Plain-English translation of NCT06986460 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a treatment called repetitive transcranial magnetic stimulation (rTMS) — a noninvasive procedure that uses magnetic pulses to stimulate a specific area of the brain — for people with bipolar depression who have not responded to previous treatments. The study will deliver 30 sessions of this brain stimulation and track whether it helps reduce depression symptoms while remaining safe.
Many people with bipolar disorder struggle with depressing episodes that don't improve with standard medications or other treatments, leaving them with limited options. This trial is designed to build evidence that this brain stimulation approach could help people who are stuck and suffering without many alternatives.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic daily for 30 days to receive the brain stimulation treatment, with each session lasting about 20–40 minutes. During this time, researchers will check your depression and mood symptoms regularly — about every 5 treatments — using simple rating scales. After the 30 treatment days are complete, you'll have follow-up visits at 1 week and 6 weeks to see how you're doing and whether the treatment has helped.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Canada